Novozymes aims to grow bioenergy with yeast and more business in Brazil

Novozymes is banking on larger sales of its yeast product Innova and deeper penetration into the Latin American market creating growth for the bioenergy division in 2020. However, the business area is simply bound to high uncertainty, says CFO Lars Green.
Photo: Novo Nordisk / PR
Photo: Novo Nordisk / PR

The stage was set for a real nightmarish read from Novozymes when the Danish enzyme maker presented its annual financial statement Thursday morning.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    On June 1, Senvion's former CFO Manav Sharma started as US country manager for Nordex. Soon he will have a new factory at his disposal. | Photo: Senvion

    Nordex restarts production in the US

    For subscribers

    Further reading